IQ-AI Limited Imaging Biometrics Adds to Development Team (9880A)
27 January 2020 - 8:29PM
UK Regulatory
TIDMIQAI
RNS Number : 9880A
IQ-AI Limited
27 January 2020
IQ-AI Ltd
("IQ-AI" or the "Company")
IQ-AI's Subsidiary Imaging Biometrics Adds to Development
Team
IQ-AI is pleased to announce its subsidiary, Imaging Biometrics,
LLC (IB), has enlisted the services of Jay Urbain, PhD to its
software development team. Dr. Urbain brings significant experience
in machine learning, deep learning, and data science, with
significant contributions across multiple industrial applications
including healthcare.
Dr. Urbain started his career at Marquette Medical Systems (now
part of GE Healthcare) and for the past 16 years held the position
of professor at the Milwaukee School of Engineering where he
developed and taught courses in artificial intelligence and general
computer science topics. As an nVidia Certified Deep Learning
Instructor, Dr. Urbain conducts deep learning workshops in
collaboration with nVidia and his research passion is at the
intersection of machine learning and healthcare. He remains an
adjunct professor at the Milwaukee School of Engineering as well as
at the Medical College of Wisconsin.
Michael Schmainda, non-executive director of IQ-AI, said, "We
are very excited that Dr. Urbain has joined IB's development team.
His background and expertise dovetail perfectly with IB's existing
team of software engineers, and will catalyze the development of
new technologies and products".
The Directors of the Company accept responsibility for the
contents of this announcement.
-ENDS-
For further information, please contact:
IQ-AI Limited
Trevor Brown/Vinod Kaushal/Qu Li
Tel: 020 7469 0930
----------------------------------------------------------
Peterhouse Capital Limited (Financial Adviser and Broker)
Lucy Williams/Heena Karani
Tel: 020 7220 9797
----------------------------------------------------------
About IQ-AI Ltd
IQ-AI, Ltd, the parent company of StoneChecker(R) and Imaging
Biometrics(R), is focused on advanced and state of the art medical
software and services. (IQ-AI.ltd). Imaging Biometrics develops and
provides visualization and analytical solutions that enable
clinicians to better diagnose and treat diseases with greater
confidence. Through close collaboration with researchers and
clinicians, sophisticated advancements are translated into
platform-independent software plug-ins which can extend the base
functionality of workstations, imaging systems, PACS, or medical
viewers. By design, IB's advanced visualization software seamlessly
integrates into routine workflows. Please visit
www.imagingbiometrics.com for further information.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
STRGCGDBUDDDGGR
(END) Dow Jones Newswires
January 27, 2020 04:29 ET (09:29 GMT)
Iq-ai (LSE:IQAI)
Historical Stock Chart
From Apr 2024 to May 2024
Iq-ai (LSE:IQAI)
Historical Stock Chart
From May 2023 to May 2024